Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SWX/ABT stock hub

SWX/ABT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/ABTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

114.2B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/ABT

In the news

Latest news · SWX/ABT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15

P25 15.9P50 20.7P75 33.1

Trailing P/E22.8

P25 19.6P50 21.4P75 37.6

ROE12.3

P25 -6.1P50 7.9P75 17

ROIC9.6

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/ABT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CH
Employees	115,000
Employees Change	7,000%
Employees Change Percent	6.09
Enterprise value	CHF 135.6B
Exchange	SIX Swiss Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Isin	US0028241000
Last refreshed	2026-05-10
Market cap	CHF 114.2B
Price	CHF 84.5
Price currency	CHF
Rev Per Employee	314,807.69x
Sector	Healthcare
Sic	3845
Symbol	swx/ABT
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.39%
EV Earnings	27.03x
EV/EBIT	20.32x
EV/EBITDA	14.37x
EV/FCF	22.91x
EV/Sales	3.86x
FCF yield	5.18%
Forward P/E	14.97x
P/B ratio	2.7x
P/E ratio	22.77x
P/S ratio	3.15x
PE Ratio10 Y	50.34x
PE Ratio3 Y	27.72x
PE Ratio5 Y	27.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.01%
EBITDA Margin	26.02%
FCF margin	16.35%
Gross margin	56.5%
Gross Profit	CHF 20.5B
Gross Profit Growth	7.63%
Gross Profit Growth Q	6.52%
Gross Profit Growth3 Y	3.39%
Gross Profit Growth5 Y	3.61%
Net Income	CHF 5B
Net Income Growth	-53.52%
Net Income Growth Q	-18.72%
Net Income Growth Years	0%
Net Income Growth3 Y	2.62%
Net Income Growth5 Y	1.88%
Pretax Margin	18.03%
Profit Margin	13.91%
Profit Per Employee	CHF 43,607
Profitable Years	41
ROA	5.59
Roa5y	6.84
ROCE	9.32
ROE	12.33
Roe5y	19.7
ROIC	9.63
Roic5y	14.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.56%
Cagr15y	6.33%
Cagr1y	-18.67%
Cagr20y	4.81%
Cagr3y	-0.61%
Cagr5y	-4.33%
Div CAGR10	7.21%
Div CAGR3	1.39%
Div CAGR5	5.5%
EPS Growth	-53.65
EPS Growth Q	-19.74
EPS Growth Years	0
EPS Growth3 Y	2.78
EPS Growth5 Y	2.27
FCF Growth	10.83%
FCF Growth Q	-1.82%
FCF Growth3 Y	2.64%
FCF Growth5 Y	-0.61%
OCF Growth	5.74%
OCF Growth Q	-7.2%
OCF Growth10 Y	12.67%
OCF Growth3 Y	3.01%
OCF Growth5 Y	-0.74%
Revenue Growth	6.59x
Revenue Growth Q	7.78x
Revenue Growth Quarters	10x
Revenue Growth Years	2x
Revenue Growth3 Y	2.83x
Revenue Growth5 Y	3.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.47
Assets	CHF 88.6B
Cash	CHF 5.9B
Current Assets	CHF 19.8B
Current Liabilities	CHF 14.3B
Debt	CHF 27.4B
Debt EBITDA	CHF 2.81
Debt Equity	CHF 0.65
Debt FCF	CHF 4.63
Equity	CHF 42.3B
Interest Coverage	16.01
Liabilities	CHF 46.3B
Long Term Assets	CHF 68.8B
Long Term Liabilities	CHF 32B
Net Cash	CHF -21.5B
Net Cash By Market Cap	CHF -18.85
Net Debt EBITDA	CHF 2.29
Net Debt Equity	CHF 0.51
Net Debt FCF	CHF 3.64
Tangible Book Value	CHF -830.2M
Tangible Book Value Per Share	CHF -0.48
WACC	6.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	2.88
Net Working Capital	CHF 3.4B
Quick ratio	0.84
Working Capital	CHF 5.7B
Working Capital Turnover	CHF 4.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	-2.42%
Dividend Growth Years	12%
Dividend per share	CHF 1.94
Dividend Years	35
Dividend Yield	2.29%
Ex Div Date	2026-04-15
Last Dividend	CHF 0.49
Payout Frequency	Quarterly
Payout Ratio	66.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	172.77%
1Y total return	-18.66%
200-day SMA	94.65
3Y total return	-1.83%
50-day SMA	80.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-19.86%
All Time High	128
All Time High Change	-33.98%
All Time High Date	2021-12-16
All Time Low	16.63
All Time Low Change	408.27%
All Time Low Date	1992-10-05
ATR	0.75
Beta	0.68
Ch YTD	-14.65
High	86
High52	106
High52 Date	2025-07-30
High52ch	-20.28%
Low	84.5
Low52	67
Low52 Date	2026-05-08
Low52ch	23.36%
Ma50ch	4.66%
Price vs 200-day SMA	-10.73%
RSI	8.28
RSI Monthly	17.04
RSI Weekly	9.6
Sharpe ratio	-3.09x
Sortino ratio	-2.85
Total Return	2.26%
Tr YTD	-13.7
Tr15y	151.12%
Tr1m	3.04%
Tr1w	20.71%
Tr3m	0.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 6.9B
Operating Income Growth	9.76
Operating Income Growth Q	-18.26
Operating Income Growth3 Y	3.54
Operating Income Growth5 Y	4.05
Operating margin	19.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,731,228,666%
Net Borrowing	13,905,163,635
Shares Insiders	0.49%
Shares Institutions	80.5%
Shares Qo Q	0%
Shares Yo Y	0.03%
Short Ratio	1.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 5.4B
Average Volume	0x
Bv Per Share	23.97
CAPEX	CHF -1.7B
Ch10y	125.6
Ch15y	83.9
Ch1m	2.42
Ch1w	20.71
Ch1y	-20.28
Ch20y	62.03
Ch3m	-0.59
Ch3y	-7.65
Ch5y	-27.16
Ch6m	-14.65
Change	-3.98%
Change From Open	-1.74
Close	88
Days Gap	-2.27
Depreciation Amortization	2,457,508,665
Dollar Volume	845
Earnings Date	2026-04-16
EBIT	CHF 6.9B
EBITDA	CHF 9.4B
EPS	CHF 2.86
F Score	5
FCF	CHF 5.9B
FCF EV Yield	4.37x
Financing CF	10,474,885,080
Fiscal Year End	December
Founded	1,888
Goodwill	27,365,132,055
Graham Number	51.10426
Graham Upside	-39.52
Income Tax	CHF 1.5B
Investing CF	-17,868,025,120
Is Primary Listing	0
Last Earnings Date	2026-04-16
Last Report Date	2026-03-31
Lynch Fair Value	CHF 18.55
Lynch Upside	-78.04
Ma150	91.99
Ma150ch	-8.14%
Ma20	74.13
Ma20ch	14%
Net CF	217,374,520
Next Earnings Date	2026-07-15
Open	86
P FCF Ratio	19.3
P OCF Ratio	15.04
Payment Date	2026-05-15
Position In Range	0
Ppne	9,616,372,035
Price Date	2026-03-11
Price EBITDA	CHF 12.12
Relative Volume	10x
Revenue	36,202,884,080x
SBC By Revenue	1.53x
Share Based Comp	555,067,040
Tax By Revenue	4.12x
Tax Rate	22.87%
Tr20y	155.82%
Tr6m	-13.7%
Volume	10
Z Score	3.65

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/ABT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$1.94 annual per share

Payout ratio

+66.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.5%

12 consecutive years of growth

Total shareholder yield

+2.3%

Next ex-dividend date: 2026-04-15

Performance

SWX/ABT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/ABT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.5%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SWX/ABT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

8.3

Below 30: short-term oversold

Price vs 200-day MA

-10.7%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

-3.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/ABT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/ABT stock rating?

swx/ABT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/ABT analysis?

The full report lives at /stocks/swx/ABT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/ABT?

The latest report frames swx/ABT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/ABT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.